Low CD2AP expression has been associated with poor prognosis in gastric cancer and renal clear cell carcinoma patients, and its reduction in vitro triggers unfavorable partial EMT processes in colon cancer cells (Xie et al., 2020; Kurilla et al., 2023; Chen et al., 2024). This evidence concerns the gene CD2AP and malignant colon neoplasm.